| (18) FDG PET/CT in the early assessment of NSCLC response to immunotherapy: results from a prospective study O Humbert, N Cadour, M Paquet, D Chardin, J Otto, J Darcourt EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | | 2019 |
| [18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management … M Masse, D Chardin, P Tricarico, V Ferrari, N Martin, J Otto, J Darcourt, ... European Journal of Nuclear Medicine and Molecular Imaging, 1-13, 2024 | | 2024 |
| [18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression B Dadone-Montaudié, D Ambrosetti, M Dufour, J Darcourt, F Almairac, ... PLoS One 12 (9), e0184625, 2017 | 30 | 2017 |
| 148 Predictive factors of Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: analysis of diastolic function G Quilichini, A Cochet, C Touzery, M Toubeau, I Dygai-Cochet, ... Archives of Cardiovascular Diseases Supplements 2 (1), 47, 2010 | | 2010 |
| 18 [F]-FDG Tumoral Uptake and Metabolic Response after 1 Cycle of Primary Chemotherapy According to Tumoral Phenotype of Breast Cancer A Berriolo-Riedinger, O Humbert, JM Riedinger, L Arnoud, B Coudert, ... CANCER RESEARCH 70, 2010 | | 2010 |
| 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions O Humbert, V Bourg, L Mondot, J Gal, PY Bondiau, D Fontaine, ... European journal of nuclear medicine and molecular imaging 46, 558-568, 2019 | 46 | 2019 |
| 18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations A Cochet, I Dygai-Cochet, JM Riedinger, O Humbert, A Berriolo-Riedinger, ... European journal of nuclear medicine and molecular imaging 41, 428-437, 2014 | 85 | 2014 |
| 18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns O Humbert, N Cadour, M Paquet, R Schiappa, M Poudenx, D Chardin, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 1158-1167, 2020 | 85 | 2020 |
| 18F-choline positron emission tomography/computed tomography and multiparametric magnetic resonance imaging for the detection of early local recurrence of prostate cancer … S Kanoun, P Walker, JM Vrigneaud, E Depardon, V Barbier, O Humbert, ... International Journal of Radiation Oncology* Biology* Physics 97 (5), 986-994, 2017 | 18* | 2017 |
| 18F-FDG PET baseline tumoral uptake and early response to neoadjuvant chemotherapy: relevance of breast cancer subtype A Berriolo-Riedinger, O Humbert, J Riedinger, B Coudert, L Arnould, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 38, S217-S217, 2011 | | 2011 |
| 18F-FDG PET–derived tumor blood flow changes after 1 cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer O Humbert, JM Riedinger, JM Vrigneaud, S Kanoun, I Dygai-Cochet, ... Journal of Nuclear Medicine 57 (11), 1707-1712, 2016 | 41 | 2016 |
| 18F-FDG PET/CT for staging and restaging of breast cancer D Groheux, A Cochet, O Humbert, JL Alberini, E Hindié, D Mankoff Journal of Nuclear Medicine 57 (Supplement 1), 17S-26S, 2016 | 188 | 2016 |
| 18F-FDOPA PET for the diagnosis of cortico-basal syndromes J Darcourt, A Schiazza, D Chardin, A El Ouartassi, N Sapin, P Koulibaly, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (SUPPL 1 …, 2021 | | 2021 |
| 18FDG PET/CT and Machine Learning for the prediction of lung cancer response to immunotherapy H Schmutz, PA Mattei, S Contu, D Chardin, O Humbert EANM 2022-35th Annual Congres-Annual Congress of the European Association of …, 2022 | | 2022 |
| 297P Transcriptomic modification induced by the first cycle of neoadjuvant chemotherapy impacts response to treatment in triple-negative breast cancer (TNBC) I Desmoulins, D Chardin, C Richard, L Arnould, R Boidot, O Humbert Annals of Oncology 32, S494, 2021 | | 2021 |
| A new PET whole body dynamic acquisition technique: feasibility and comparison to dual point imaging N Cadour, M Koulibaly, J Benoliel, M Paquet, A Schiazza, D Benisvy, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 45, S212-S212, 2018 | | 2018 |
| Abstract P2-16-14: HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative … L Vincent, C Jankowski, M Cortet, L Arnould, S Ladoire, B Coudert, ... Cancer Research 80 (4_Supplement), P2-16-14-P2-16-14, 2020 | | 2020 |
| Abstract P2-26-23: Transcriptomic modification induced by the first cycle of neoadjuvant chemotherapy impacts response to treatment in triple negative breast cancer (TNBC) I Desmoulins, D Chardin, C Richard, L Arnould, A COCHET, O Humbert, ... Cancer Research 83 (5_Supplement), P2-26-23-P2-26-23, 2023 | | 2023 |
| Abstract P5-01-05: Prognostic Value at 4 Years of FDG PET, after the First Course of Neoadjuvant Chemotherapy in Breast Cancer O Humbert, A Berriolo-Riedinger, L Arnoud, B Coudert, M Toubeau, ... Cancer Research 70 (24_Supplement), P5-01-05-P5-01-05, 2010 | | 2010 |
| Abstract P5-01-06: 18 [F]-FDG Tumoral Uptake and Metabolic Response after 1 Cycle of Primary Chemotherapy According to Tumoral Phenotype of Breast Cancer A Berriolo-Riedinger, O Humbert, JM Riedinger, L Arnoud, B Coudert, ... Cancer Research 70 (24_Supplement), P5-01-06-P5-01-06, 2010 | | 2010 |
